Promega Corporation

CLK1 Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant human CLK1 (129–end) was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. CLK1, also known as STY, is a member of the CDC2-like (or LAMMER) family of dual specificity protein kinases. The phosphorylated serine/arginine-rich (SR) proteins are involved in the pre-mRNA processing and releasing through nucleus into nucleoplasm. CLK1, which could phosphorylate the specific SR proteins (1) such as ASF/SF2, may directly regulate the activity and compartmentalization of SR splicing factors (2).

ADP-Glo™ Kinase Assay is a luminesce...

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for China customers only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart
CLK1 Kinase Enzyme System
Close Window

CLK1 Kinase Enzyme System  Components

10μg
- V4056 ¥ 5,795.00 Add to cart

CLK1 Kinase Enzyme System

Close Window

CLK1 Kinase Enzyme System

 Components

1mg
- V6288 ¥ 71,143.00 Add to cart
ADP-Glo™ Kinase Assay + CLK1 Kinase Enzyme System
Close Window

ADP-Glo™ Kinase Assay + CLK1 Kinase Enzyme System  Components

  • CLK1 Kinase Enzyme System

    V40561 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V4057 ¥ 8,713.00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V4056, V6288, V4057 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V4057 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V4057 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V4057 U.S. Pat. No. 7,741,067 and other patents and patents pending.

V4057 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V4057 U.S. Pat. No. 8,183,007 and other patents pending.

V4057 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V4057 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.